These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20225394)

  • 21. The efficacy of glycemic control with continuous glucose monitoring on atheroma progression: rationale and design of the Observation of Coronary Atheroma Progression under Continuous Glucose Monitoring Guidance in Patients with Type 2 Diabetes Mellitus (OPTIMAL).
    Kataoka Y; Hosoda K; Makino H; Matsubara M; Matsuo M; Ohata Y; Koezuka R; Tamanaha T; Tomita T; Honda-Kohmo K; Noguchi M; Son C; Nishimura K; Asaumi Y; Miyamoto Y; Noguchi T; Yasuda S
    Cardiovasc Diagn Ther; 2019 Oct; 9(5):431-438. PubMed ID: 31737515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between glycemic control and coronary artery disease severity, prevalence and plaque characteristics by computed tomography coronary angiography in asymptomatic type 2 diabetic patients.
    Tavares CA; Rassi CH; Fahel MG; Wajchenberg BL; Rochitte CE; Lerario AC
    Int J Cardiovasc Imaging; 2016 Oct; 32(10):1577-85. PubMed ID: 27432440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asymptomatic coronary artery disease in a Norwegian cohort with type 2 diabetes: a prospective angiographic study with intravascular ultrasound evaluation.
    Arora S; Ofstad AP; Ulimoen GR; Birkeland KI; Endresen K; Gullestad L; Johansen OE
    Cardiovasc Diabetol; 2019 Mar; 18(1):26. PubMed ID: 30851727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of glycemic variability and glycated hemoglobin as risk factors of coronary artery disease in patients with undiagnosed diabetes.
    Mi SH; Su G; Li Z; Yang HX; Zheng H; Tao H; Zhou Y; Tian L
    Chin Med J (Engl); 2012 Jan; 125(1):38-43. PubMed ID: 22340463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is glycaemia or insulin dose the stronger risk factor for coronary artery disease in type 1 diabetes?
    Conway B; Costacou T; Orchard T
    Diab Vasc Dis Res; 2009 Oct; 6(4):223-30. PubMed ID: 20368215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes.
    Su G; Mi S; Tao H; Li Z; Yang H; Zheng H; Zhou Y; Ma C
    Cardiovasc Diabetol; 2011 Feb; 10():19. PubMed ID: 21349201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral glucose tolerance test and HbA₁c for diagnosis of diabetes in patients undergoing coronary angiography: [corrected] the Silent Diabetes Study.
    Doerr R; Hoffmann U; Otter W; Heinemann L; Hunger-Battefeld W; Kulzer B; Klinge A; Lodwig V; Amann-Zalan I; Sturm D; Tschoepe D; Spitzer SG; Stumpf J; Lohmann T; Schnell O
    Diabetologia; 2011 Nov; 54(11):2923-30. PubMed ID: 21773683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non-diabetic patients undergoing coronary angiography.
    Arbel Y; Zlotnik M; Halkin A; Havakuk O; Berliner S; Herz I; Rabinovich I; Keren G; Bazan S; Finkelstein A; Banai S
    Clin Res Cardiol; 2014 Mar; 103(3):223-7. PubMed ID: 24271460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary artery disease severity modifies associations between glycemic control and both mortality and myocardial infarction.
    Raghavan S; Liu WG; Michael Ho P; Plomondon ME; Barón AE; Caplan L; Joynt Maddox KE; Magid D; Saxon DR; Voils CI; Bradley SM; Maddox TM
    J Diabetes Complications; 2018 May; 32(5):480-487. PubMed ID: 29483016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression of coronary artery calcification is stronger in poorly than in well controlled diabetes: Results from the Heinz Nixdorf Recall Study.
    Kowall B; Lehmann N; Mahabadi AA; Moebus S; Budde T; Seibel R; Grönemeyer D; Erbel R; Jöckel KH; Stang A
    J Diabetes Complications; 2017 Jan; 31(1):234-240. PubMed ID: 27665253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-diabetic hyperglycaemia correlates with angiographic coronary artery disease prevalence and severity.
    Konstantinou DM; Chatzizisis YS; Louridas GE; Parcharidis GE; Giannoglou GD
    Diabetes Metab; 2010 Nov; 36(5):402-8. PubMed ID: 20594891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do the extent and direction of arterial remodelling predict subsequent progression of coronary atherosclerosis? A serial intravascular ultrasound study.
    Sipahi I; Tuzcu EM; Moon KW; Nicholls SJ; Schoenhagen P; Zhitnik J; Crowe TD; Kapadia S; Nissen SE
    Heart; 2008 May; 94(5):623-7. PubMed ID: 18070944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of acarbose on carotid intima-media thickness in patients with newly diagnosed impaired glucose tolerance or mild type 2 diabetes mellitus: A one-year, prospective, randomized, open-label, parallel-group study in Japanese adults with established coronary artery disease.
    Koyasu M; Ishii H; Watarai M; Takemoto K; Inden Y; Takeshita K; Amano T; Yoshikawa D; Matsubara T; Murohara T
    Clin Ther; 2010 Aug; 32(9):1610-7. PubMed ID: 20974318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting.
    Kassaian SE; Goodarzynejad H; Boroumand MA; Salarifar M; Masoudkabir F; Mohajeri-Tehrani MR; Pourhoseini H; Sadeghian S; Ramezanpour N; Alidoosti M; Hakki E; Saadat S; Nematipour E
    Cardiovasc Diabetol; 2012 Jul; 11():82. PubMed ID: 22805289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of glycemic state on postprandial hyperlipidemia and hyperinsulinemia in patients with coronary artery disease.
    Nakamura A; Monma Y; Kajitani S; Noda K; Nakajima S; Endo H; Takahashi T; Nozaki E
    Heart Vessels; 2016 Sep; 31(9):1446-55. PubMed ID: 26439243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between blood glucose variability and coronary plaque instability in patients with acute coronary syndromes.
    Okada K; Hibi K; Gohbara M; Kataoka S; Takano K; Akiyama E; Matsuzawa Y; Saka K; Maejima N; Endo M; Iwahashi N; Tsukahara K; Kosuge M; Ebina T; Fitzgerald PJ; Honda Y; Umemura S; Kimura K
    Cardiovasc Diabetol; 2015 Aug; 14():111. PubMed ID: 26289581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of glucose control on coronary plaque composition in patients with diabetes mellitus.
    Yang DJ; Lee MS; Kim WH; Park HW; Kim KH; Kwon TG; Kim SW; Rihal CS; Lerman A; Bae JH
    J Invasive Cardiol; 2013 Mar; 25(3):137-41. PubMed ID: 23468443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of chronic kidney disease on coronary plaque components in coronary artery disease patients with both diabetes mellitus and hypertension.
    Shigemoto E; Iwata A; Futami M; Kato Y; Yamashita M; Imaizumi S; Kuwano T; Ike A; Sugihara M; Saku K; Miura SI
    Heart Vessels; 2019 Jul; 34(7):1065-1075. PubMed ID: 30607540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of carotid intima media thickness in impaired fasting glucose and impaired glucose tolerance.
    Aydin Y; Berker D; Ustün I; Gül K; Erden G; Kutlucan A; Yilmaz Aydin L; Güler S
    Minerva Endocrinol; 2011 Sep; 36(3):171-9. PubMed ID: 22019748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycosylated hemoglobin and coronary artery disease in patients without diabetes mellitus.
    Verdoia M; Schaffer A; Cassetti E; Barbieri L; Di Ruocco MV; Perrone-Filardi P; Marino P; De Luca G;
    Am J Prev Med; 2014 Jul; 47(1):9-16. PubMed ID: 24750972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.